Skip to main content

12 Result(s)

within C. Scheid Remove this filter Public Health Remove this filter

and

  1. Article

    Open Access

    Insulin eye drops for severe refractory chronic ocular graft-versus-host disease

    V. Tahmaz, L. Menghesha, M. E. Stern, U. Holtick, C. Scheid… in Bone Marrow Transplantation (2024)

    Download PDF (434 KB) View Article

  2. No Access

    Article

    Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT

    The optimal conditioning for patients with higher risk MDS receiving potentially curative allogeneic haematopoietic stem cell transplant(allo-HCT) remains to be defined. This is particularly the case for patie...

    V. Potter, L. Gras, L. Koster, N. Kroger, K. Sockel… in Bone Marrow Transplantation (2024)

  3. No Access

    Article

    Adverse environmental conditions are a risk factor for ocular GvHD after allogeneic hematopoietic stem cell transplantation

    P. Steven, C. Faust, U. Holtick, C. Scheid, V. Tahmaz… in Bone Marrow Transplantation (2020)

  4. No Access

    Article

    Impact of choice, timing, sequence and combination of broad-spectrum antibiotics on the outcome of allogeneic haematopoietic stem cell transplantation

    Recent data link the incidence of intestinal GvHD (iGvHD) after allogeneic haematopoietic stem cell transplantation (aSCT) to exposure with piperacillin–tazobactam or imipenem–cilastatin. To assess relevance o...

    F Farowski, V Bücker, J J Vehreschild, L Biehl… in Bone Marrow Transplantation (2018)

  5. Article

    Open Access

    Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party

    The International Prognostic Scoring System has been revised (IPSS-R) to predict prognosis of patients with myelodysplastic syndromes at diagnosis. To validate the use of the IPSS-R assessed before transplant ...

    C Scheid, L de Wreede, A van Biezen, C Koenecke, G Göhring… in Bone Marrow Transplantation (2017)

    Download PDF (845 KB) View Article

  6. No Access

    Article

    Meibography and meibomian gland measurements in ocular graft-versus-host disease

    Meibomian gland loss in ocular GvHD was described as a mechanism contributing to dry eye and severe damage to the ocular surface. Infrared images of upper eyelid meibomian glands from 86 ocular GvHD patients, ...

    L A Engel, S Wittig, F Bock, L Sauerbier, C Scheid… in Bone Marrow Transplantation (2015)

  7. No Access

    Article

    Optimization of health-care organization and perceived improvement of patient comfort by switching from intra-venous BU four-times-daily infusions to a once-daily administration scheme in adult hematopoietic stem cell recipients

    Previous studies have shown an equivalent pharmacokinetic profile between four-times-daily (4QD) and once-daily (QD) administration of intra-venous (IV) BU, without increased toxicity. We assess the impact of ...

    A Xhaard, P Rzepecki, D Valcarcel, S Santarone, S Fürst… in Bone Marrow Transplantation (2014)

  8. No Access

    Article

    Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USA

    We describe 20 patients with myeloma and 1 with primary amyloidosis from 15 centres, all with advanced renal failure, most of whom had PBSC mobilised using plerixafor following previous failed mobilisation by ...

    K W Douglas, A N Parker, P J Hayden, A Rahemtulla, A D'Addio… in Bone Marrow Transplantation (2012)

  9. No Access

    Article

    Trimethoprim/sulfamethoxazole prophylaxis impairs function of mobilised autologous peripheral blood stem cells

    M Fuchs, C Scheid, A Schulz, V Diehl, D Söhngen in Bone Marrow Transplantation (2000)

  10. No Access

    Article

    Using at least 5×106/kg CD34+ cells for autologous stem cell transplantation significantly reduces febrile complications and use of antibiotics after transplantation

    For autologous stem cell transplantation, it is common practice to infuse at least 2 × 106/kg CD34+ cells to ensure rapid engraftment. However it was recently claimed that increasing the threshold to 5×106/kg lea...

    C Scheid, A Draube, M Reiser, A Schulz, J Chemnitz, S Nelles… in Bone Marrow Transplantation (1999)

  11. No Access

    Article

    Successful peripheral blood stem cell mobilization with etoposide (VP-16) in patients with relapsed or resistant lymphoma who failed cyclophosphamide mobilization

    High-dose chemotherapy (HDCT) followed by autologous blood stem cell transplantation is considered the treatment of choice for patients with relapsed or resistant aggressive non-Hodgkin’s lymphoma (NHL) or Hod...

    M Reiser, A Josting, A Draube, MY Mapara, C Scheid… in Bone Marrow Transplantation (1999)

  12. No Access

    Article

    Analysis of rhG-CSF-effects on platelets by in vitro bleeding test and transcranial Doppler ultrasound examination

    Experimental evidence suggests a stimulatory effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on both platelets and coagulation. RhG-CSF is increasingly used to stimulate healthy vol...

    D Söhngen, S Wienen, M Siebler, C Boogen, C Scheid, A Schulz… in Bone Marrow Transplantation (1998)